Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Ellis

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Occupational Medicine (Oxford, England)|September 14, 2018
ReplyPaul R Ellis, Gareth I Walters
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 25, 2020
Exacerbations of Lung Disease in Alpha-1 Antitrypsin DeficiencyDaniel J Smith, Paul R Ellis, Alice M Turner
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 28, 2019
Alpha-1 Antitrypsin Deficiency: A Predisposing Factor for the Development of Pulmonary Langerhans Cell HistiocytosisPaul R Ellis, Edward J Campbell, Alice M Turner, et al.
Thorax|September 18, 2025
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort studyFawaz Alwadani, Paul R Ellis, Michael Newnham, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 11, 2025
Proposal and Validation of the Minimum Clinically Important Difference in Emphysema ProgressionEmily S Y Ho, Paul R Ellis, Diana Kavanagh, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2023
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin DeficiencyPaul R Ellis, Kristen E Holm, Radmila Choate, et al.
Thorax|January 29, 2024
Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD)Ketan Patel, Anita Pye, Ross G Edgar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Occupational Medicine (Oxford, England)|September 14, 2018
ReplyPaul R Ellis, Gareth I Walters
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 25, 2020
Exacerbations of Lung Disease in Alpha-1 Antitrypsin DeficiencyDaniel J Smith, Paul R Ellis, Alice M Turner
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 28, 2019
Alpha-1 Antitrypsin Deficiency: A Predisposing Factor for the Development of Pulmonary Langerhans Cell HistiocytosisPaul R Ellis, Edward J Campbell, Alice M Turner, et al.
Thorax|September 18, 2025
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort studyFawaz Alwadani, Paul R Ellis, Michael Newnham, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 11, 2025
Proposal and Validation of the Minimum Clinically Important Difference in Emphysema ProgressionEmily S Y Ho, Paul R Ellis, Diana Kavanagh, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2023
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin DeficiencyPaul R Ellis, Kristen E Holm, Radmila Choate, et al.
Thorax|January 29, 2024
Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD)Ketan Patel, Anita Pye, Ross G Edgar, et al.
Pageof 1